← Evidence map

ReviewCancer immunity2013

NKG2D ligands as therapeutic targets.

Paul Spear et al.PubMed ↗Full text ↗

No numbers read from the abstract.

164 papers cite itlatest 60 shown

2013
…
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 23833565